Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
Shareholders of Kinetic Concepts Inc. approve a $68.50-per-share leveraged buyout worth $6.3 billion by private equity firm Apax Partners and two Canadian pension fund partners.
The U.S. government glossed over cancer concerns as it rolled out airport X-ray scanners, according to a ProPublica report.
The Juvenile Diabetes Research Foundation unveiled a petition, signed by more than 100,000 senators, doctors and Type I diabetes patients, urging the FDA to issue swift and clear guidance for the development of an artificial pancreas for diabetics.
The U.S. Supreme court refused to hear an appeal by Stryker Corp. (NYSE:SYK) in a product liability lawsuit filed over its recalled Trident hip implant.
Boston Scientific Corp. (NYSE:BSX) COO Samuel Leno announced his retirement as executive VP and chief operating officer after three years with med-tech giant. Leno’s retirement will be effective by the end of this year.
The FDA seeks public and industry input about the efficacy and clarity of its medical device labeling system. The federal watchdog agency plans to ask health care providers how easy it is to follow instructions on medical devices, how organized the information is and how useful they find it.
Medtronic (NYSE:MDT) CEO Omar Ishrak put the kaibosh on a spinout for the company’s spine business, telling Reuters that all of the company’s parts add up to a greater whole, with one notable exception – its Physio-Control external defibrillator unit.